Related Experiment Video
Updated: Mar 6, 2026

In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells
Published on: June 12, 2017
Autophagy-inducing natural compounds: a treasure resource for developing therapeutics against tissue fibrosis
Xiao-Xi Lv1, Shan-Shan Liu1, Zhuo-Wei Hu1
1a Immunology and Cancer Pharmacology Group, State Key Laboratory of Bioactive Substance and Function of Natural Medicines , Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College , Beijing 100050 , China.
Abstract:
Tissue fibrosis is a common pathologic change of many chronic diseases, which is characterized by extracellular matrix accumulation in tissues and dysfunction of the injured organs. Despite there recently gain mechanistic insight into the pathogenesis of tissue fibrosis, therapeutics for tissue fibrosis and thus many chronic diseases remain a significant clinical unmet need. Recent progressions indicate that autophagy, a conserved lysosomal degradation process in eukaryotic cells, not only plays an important regulatory role in maintaining cellular and tissue homeostasis, but also contributes to the development and progression of tissue fibrosis in a diversity of organs. Interestingly, a number of natural compounds derived from plant or Chinese Herb Medicines (CHM), have been identified as modulators of autophagy, and may function as potential therapeutic agents for the treatment of different fibrotic diseases. In this review, we focus on several plant natural compounds that have well-known anti-fibrotic effects through regulating autophagic signal pathways or autophagy activity. These findings should provide important therapeutic clues and strategy for the development of new anti-fibrosis drugs.
Insights
Natural compounds from plants and Chinese Herbal Medicines (CHM) show promise in treating tissue fibrosis by regulating autophagy. These autophagy modulators offer potential new therapeutic strategies for fibrotic diseases.
Area of Science:
- Biomedical Sciences
- Cell Biology
- Pharmacology
Background:
- Tissue fibrosis, marked by extracellular matrix buildup, is a hallmark of chronic diseases with limited treatment options.
- Autophagy, a cellular degradation process, is increasingly recognized for its role in both maintaining homeostasis and contributing to fibrotic disease progression.
- Current therapeutic strategies for fibrotic conditions remain insufficient, highlighting a significant unmet clinical need.
Purpose of the Study:
- To review natural compounds, particularly from plants and Chinese Herbal Medicines (CHM), that modulate autophagy.
- To explore the anti-fibrotic effects of these compounds through their regulation of autophagic pathways.
- To identify potential therapeutic agents for treating various fibrotic diseases.
Main Methods:
- Literature review focusing on studies investigating natural compounds and their impact on autophagy.
- Analysis of research detailing the mechanisms by which plant-derived compounds affect autophagic activity.
- Examination of evidence linking autophagy modulation to anti-fibrotic effects in different organ systems.
Main Results:
- Several plant-derived natural compounds have demonstrated significant anti-fibrotic properties.
- These compounds exert their effects by modulating key autophagic signal pathways or overall autophagy activity.
- Evidence suggests these compounds can counteract the excessive extracellular matrix accumulation characteristic of fibrosis.
Conclusions:
- Natural compounds modulating autophagy represent a promising avenue for developing novel anti-fibrosis therapeutics.
- Targeting autophagy pathways with plant-derived agents offers a potential strategy to combat fibrotic diseases.
- Further research into these compounds could lead to new drug development for chronic fibrotic conditions.
More Related Videos
06:33Author Spotlight: Exploring Orofacial Muscle Regeneration – Insights and Innovations
Published on: December 29, 2023
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
Related Concept Videos
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Drugs that Stabilize Microtubules
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Tissue Renewal without Stem Cells
However, failure of such a system...